HumbleHuman
liked
$Sangamo Therapeutics(SGMO.US$ added it was eligible to earn up to $220M in milestone payments and product sales royalties of 14% to 20% if the therapy is approved and commercialized. This is why i'm holding.
3
HumbleHuman
liked
Sangamo Therapeutics Reports on Pfizer’s Announcement of Positive Topline Results From Phase 3 Trial of Hemophilia a Gene Therapy Candidate.
![🚀🚀HC Wainwright & Co. Reiterates Buy on Sangamo Therapeutics, Maintains $5 Price Target](https://sgsnsimg.moomoo.com/sns_client_feed/101534139/20240725/55a4ed75cd7699729ee0a924e60ee60b.jpg/thumb?area=101&is_public=true)
2
HumbleHuman
liked
$Sangamo Therapeutics(SGMO.US$ stock is up after the company announced a successful late-stage trial.
This treatment for patients with hemophilia A appears to have the efficacy and safety metrics in place to warrant a potential approval.
Notably, Sangamo’s candidate is being developed alongside $Pfizer(PFE.US$ , adding a layer of clout to the R&D behind the prospective treatment.
This treatment for patients with hemophilia A appears to have the efficacy and safety metrics in place to warrant a potential approval.
Notably, Sangamo’s candidate is being developed alongside $Pfizer(PFE.US$ , adding a layer of clout to the R&D behind the prospective treatment.
![Why Is SGMO Stock Up 40% Today?](https://ussnsimg.moomoo.com/sns_client_feed/70042970/20240725/a3a2b19629744c8bb63696800989aa5b.jpg/thumb?area=100&is_public=true)
4
1
HumbleHuman
liked
$Sangamo Therapeutics(SGMO.US$ its being funded by $Pfizer(PFE.US$ that says it all… Holding - adding weekly here
2